Adriaan D. de Jongh

An old friend who has overstayed their welcome: the ALSFRS-R total score as primary endpoint for ALS clinical trials

Ruben P. A. van Eijk, Adriaan D. de Jongh, Stavros Nikolakopoulos et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2021 · 60 citations · Full text

Innovating Clinical Trials for Amyotrophic Lateral Sclerosis

Ruben P. A. van Eijk, Stavros Nikolakopoulos, Kit C. B. Roes et al. · Neurology · 2021 · 34 citations · Full text

Incidence, Prevalence, and Geographical Clustering of Motor Neuron Disease in the Netherlands

Adriaan D. de Jongh, Ruben P. A. van Eijk, Susan M. Peters et al. · Neurology · 2021 · 31 citations · Full text

Using the ALSFRS-R in multicentre clinical trials for amyotrophic lateral sclerosis: potential limitations in current standard operating procedures

Jaap N.E. Bakers, Adriaan D. de Jongh, Tommy M. Bunte et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2021 · 21 citations · Full text

Characterising ALS disease progression according to El Escorial and Gold Coast criteria

Adriaan D. de Jongh, Nathalie Braun, Markus Weber et al. · Journal of Neurology Neurosurgery & Psychiatry · 2022 · 20 citations